Scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae

Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide, allowing immune system cells called neutrophils to attack and kill the bacteria.
Latest Science News — ScienceDaily

Play
Arrow
Arrow
Slider